Ghorbani, Anahita

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation

GDF15 and Related BiomarkersHeart Failure Treatment and Management

Cited by 482

A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction

Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology

Metabolomics and Mass Spectrometry StudiesChronic Kidney Disease and Diabetes

Cited by 307

Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals

Ho, J. E., Arora, P., Walford, G. A., Ghorbani, A., Guanaga, D. P., Dhakal, B. P., Nathan, D. I., Buys, E. S., Florez, J. C., Newton‐Cheh, C., et al. (2014) · Journal of the American Heart Association

Phosphodiesterase function and regulationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 39